DK1943240T3 - Kemisk fremgangsmåde - Google Patents

Kemisk fremgangsmåde

Info

Publication number: DK1943240T3
Authority: DK; Denmark
Prior art keywords: chemical process; chemical
Prior art date: 2005-09-30

Application number

DK06794582.4T

Other languages

English (en)

Inventor

Joergen Blixt

Michael David Golden

Philip John Hogan

David Michael Glanville Martin

Francis Joseph Montgomery

Zakariya Patel

John David Pittam

George Joseph Sependa

Christopher John Squire

Nicholas Cartwright Alexander Wright

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-30

Filing date

2006-09-27

Publication date

2010-03-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35395001&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1943240(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2010-03-01 Application granted granted Critical

2010-03-01 Publication of DK1943240T3 publication Critical patent/DK1943240T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK06794582.4T 2005-09-30 2006-09-27 Kemisk fremgangsmåde DK1943240T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0519879.1A GB0519879D0 (en)	2005-09-30	2005-09-30	Chemical process
PCT/GB2006/003587 WO2007036713A2 (en)	2005-09-30	2006-09-27	Chemical process

Publications (1)

Publication Number	Publication Date
DK1943240T3 true DK1943240T3 (da)	2010-03-01

Family

ID=35395001

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK09152654.1T DK2053048T3 (da)	2005-09-30	2006-09-27	Fremgangsmåde til in situ kemisk sulfonering
DK06794582.4T DK1943240T3 (da)	2005-09-30	2006-09-27	Kemisk fremgangsmåde

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK09152654.1T DK2053048T3 (da)	2005-09-30	2006-09-27	Fremgangsmåde til in situ kemisk sulfonering

Country Status (32)

Country	Link
US (8)	US8163926B2 (da)
EP (2)	EP1943240B1 (da)
JP (2)	JP5213715B2 (da)
KR (1)	KR101307641B1 (da)
CN (3)	CN102503898B (da)
AR (1)	AR055671A1 (da)
AT (2)	ATE481399T1 (da)
AU (1)	AU2006296367B2 (da)
BR (1)	BRPI0616715A2 (da)
CA (2)	CA2624045C (da)
CY (2)	CY1110275T1 (da)
DE (2)	DE602006017004D1 (da)
DK (2)	DK2053048T3 (da)
ES (2)	ES2335435T3 (da)
GB (1)	GB0519879D0 (da)
HK (2)	HK1122553A1 (da)
HR (2)	HRP20100019T1 (da)
IL (2)	IL190172A (da)
ME (2)	ME01466B (da)
MY (2)	MY149834A (da)
NO (1)	NO342152B1 (da)
NZ (2)	NZ566566A (da)
PL (2)	PL1943240T3 (da)
PT (2)	PT1943240E (da)
RS (2)	RS51515B (da)
RU (1)	RU2448102C2 (da)
SG (1)	SG165416A1 (da)
SI (2)	SI1943240T1 (da)
TW (2)	TWI424991B (da)
UY (1)	UY29824A1 (da)
WO (1)	WO2007036713A2 (da)
ZA (1)	ZA200802416B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003064413A1 (en) *	2002-02-01	2003-08-07	Astrazeneca Ab	Quinazoline compounds
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
CL2007003158A1 (es) *	2006-11-02	2008-05-16	Astrazeneca Ab	Procedimiento de preparacion de compuestos derivados de quinazolina o sus sales farmaceuticamente aceptables; compuestos intermediarios; procedimiento de preparacion.
ES2547902T3 (es) *	2011-09-01	2015-10-09	Symrise Ag	Procedimiento para la preparación de derivados de indanona
US9273001B2 (en) *	2012-08-15	2016-03-01	Glaxo Group Limited	Chemical process
CN104098544A (zh) *	2013-04-07	2014-10-15	浙江九洲药物科技有限公司	一种凡德他尼的制备方法
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4870083A (en)	1987-11-24	1989-09-26	Merrell Dow Pharmaceuticals Inc.	1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants
JP2829744B2 (ja)	1989-05-31	1998-12-02	川研ファインケミカル株式会社	ピペリジンカルボン酸類の製造方法
AU8506791A (en)	1990-10-01	1992-04-28	Janssen Pharmaceutica N.V.	Novel 4-piperidinylcarbonyl derivatives
JP2659107B2 (ja)	1991-03-28	1997-09-30	エーザイ株式会社	複素環式―環式アミン誘導体
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
CA2102780C (en)	1991-05-10	2007-01-09	Alfred P. Spada	Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
US5624926A (en)	1993-02-18	1997-04-29	Kyowa Hakko Kogyo Co., Ltd.	Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
AU680004B2 (en) *	1993-05-26	1997-07-17	Syntex (U.S.A.) Inc.	Novel 1-phenylalkanone 5-HT4 receptor ligands
DE4326344A1 (de)	1993-08-05	1995-02-09	Thomae Gmbh Dr K	Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0739336B1 (en) *	1994-01-13	1998-08-26	MERCK SHARP & DOHME LTD.	Gem-disubstituted azacyclic tachykinin antagonists
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
DE69709319T2 (de)	1996-03-05	2002-08-14	Astrazeneca Ab	4-anilinochinazolin derivate
CA2265630A1 (en)	1996-09-13	1998-03-19	Gerald Mcmahon	Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
PT1676845E (pt) *	1999-11-05	2008-08-05	Astrazeneca Ab	Novos derivados de quinazolina
GB0126879D0 (en)	2001-11-08	2002-01-02	Astrazeneca Ab	Combination therapy
AU2002366801B8 (en)	2001-12-20	2009-05-21	Osi Pharmaceuticals, Inc.	Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
WO2003064413A1 (en)	2002-02-01	2003-08-07	Astrazeneca Ab	Quinazoline compounds
ATE533750T1 (de)	2002-02-06	2011-12-15	Ube Industries	Verfahren zur herstellung einer 4- aminochinazolinverbindung
JP2006502132A (ja)	2002-08-09	2006-01-19	アストラゼネカアクチボラグ	癌の治療における血管内皮細胞増殖因子受容体の阻害薬ｚｄ６４７４と放射線療法との併用
GB0218526D0 (en)	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en)	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
EP1592423B1 (en)	2003-02-13	2011-04-20	AstraZeneca AB	Combination therapy of zd6474 with 5-fu and/or cpt-11
DE602004028834D1 (de)	2003-07-10	2010-10-07	Astrazeneca Ab	Verwendung des chinazolin-derivats zd6474 in kombination mit platinverbindungen und optional ionisierender strahlung bei der behandlung von erkrankungen im zusammenhang mit angiogenese und/oder erhöhter gefässpermeabilität
GB0318423D0 (en)	2003-08-06	2003-09-10	Astrazeneca Ab	Chemical compounds
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process

2005
- 2005-09-30 GB GBGB0519879.1A patent/GB0519879D0/en not_active Ceased
2006
- 2006-09-27 DK DK09152654.1T patent/DK2053048T3/da active
- 2006-09-27 NZ NZ566566A patent/NZ566566A/en not_active IP Right Cessation
- 2006-09-27 BR BRPI0616715-2A patent/BRPI0616715A2/pt not_active IP Right Cessation
- 2006-09-27 ES ES06794582T patent/ES2335435T3/es active Active
- 2006-09-27 MY MYPI2011003076A patent/MY149834A/en unknown
- 2006-09-27 RS RSP-2010/0520A patent/RS51515B/en unknown
- 2006-09-27 ME MEP-2013-21A patent/ME01466B/me unknown
- 2006-09-27 MY MYPI20080855A patent/MY145540A/en unknown
- 2006-09-27 SI SI200630524T patent/SI1943240T1/sl unknown
- 2006-09-27 WO PCT/GB2006/003587 patent/WO2007036713A2/en active Application Filing
- 2006-09-27 EP EP06794582A patent/EP1943240B1/en active Active
- 2006-09-27 AU AU2006296367A patent/AU2006296367B2/en not_active Ceased
- 2006-09-27 CN CN201110159729.XA patent/CN102503898B/zh active Active
- 2006-09-27 AT AT09152654T patent/ATE481399T1/de active
- 2006-09-27 SG SG201006940-9A patent/SG165416A1/en unknown
- 2006-09-27 US US12/088,680 patent/US8163926B2/en active Active
- 2006-09-27 DE DE602006017004T patent/DE602006017004D1/de active Active
- 2006-09-27 RS RSP-2010/0037A patent/RS51263B/sr unknown
- 2006-09-27 ES ES09152654T patent/ES2350513T3/es active Active
- 2006-09-27 PL PL06794582T patent/PL1943240T3/pl unknown
- 2006-09-27 CN CN201110159628.2A patent/CN102503933B/zh active Active
- 2006-09-27 JP JP2008532864A patent/JP5213715B2/ja not_active Expired - Fee Related
- 2006-09-27 CA CA2624045A patent/CA2624045C/en not_active Expired - Fee Related
- 2006-09-27 SI SI200630816T patent/SI2053048T1/sl unknown
- 2006-09-27 EP EP09152654A patent/EP2053048B8/en active Active
- 2006-09-27 ME MEP-2013-51A patent/ME01531B/me unknown
- 2006-09-27 KR KR1020087009317A patent/KR101307641B1/ko active IP Right Grant
- 2006-09-27 AT AT06794582T patent/ATE448218T1/de active
- 2006-09-27 CN CN200680036468XA patent/CN101277948B/zh active Active
- 2006-09-27 PT PT06794582T patent/PT1943240E/pt unknown
- 2006-09-27 DE DE602006010428T patent/DE602006010428D1/de active Active
- 2006-09-27 NZ NZ593930A patent/NZ593930A/xx not_active IP Right Cessation
- 2006-09-27 RU RU2008116573/04A patent/RU2448102C2/ru not_active IP Right Cessation
- 2006-09-27 PT PT09152654T patent/PT2053048E/pt unknown
- 2006-09-27 CA CA2745829A patent/CA2745829C/en not_active Expired - Fee Related
- 2006-09-27 DK DK06794582.4T patent/DK1943240T3/da active
- 2006-09-27 PL PL09152654T patent/PL2053048T3/pl unknown
- 2006-09-29 TW TW099102690A patent/TWI424991B/zh not_active IP Right Cessation
- 2006-09-29 UY UY29824A patent/UY29824A1/es unknown
- 2006-09-29 TW TW095136340A patent/TWI328580B/zh not_active IP Right Cessation
- 2006-09-29 AR ARP060104320A patent/AR055671A1/es not_active Application Discontinuation
2008
- 2008-03-11 NO NO20081267A patent/NO342152B1/no not_active IP Right Cessation
- 2008-03-13 IL IL190172A patent/IL190172A/en not_active IP Right Cessation
- 2008-03-14 ZA ZA200802416A patent/ZA200802416B/xx unknown
- 2008-12-15 HK HK08113582.9A patent/HK1122553A1/xx not_active IP Right Cessation
2009
- 2009-09-21 HK HK09108619.5A patent/HK1130478A1/xx not_active IP Right Cessation
2010
- 2010-01-11 HR HR20100019T patent/HRP20100019T1/hr unknown
- 2010-01-25 CY CY20101100076T patent/CY1110275T1/el unknown
- 2010-11-12 CY CY20101101019T patent/CY1110887T1/el unknown
- 2010-11-16 HR HR20100620T patent/HRP20100620T1/hr unknown
2011
- 2011-12-07 US US13/314,034 patent/US8865899B2/en active Active
2012
- 2012-11-28 JP JP2012259782A patent/JP5654546B2/ja not_active Expired - Fee Related
2013
- 2013-07-21 IL IL227574A patent/IL227574A/en not_active IP Right Cessation
2014
- 2014-09-09 US US14/481,302 patent/US20140378684A1/en not_active Abandoned
2015
- 2015-07-22 US US14/805,816 patent/US9815816B2/en active Active
2017
- 2017-10-27 US US15/796,615 patent/US10344015B2/en active Active
2019
- 2019-05-08 US US16/406,246 patent/US20190263782A1/en not_active Abandoned
2020
- 2020-11-02 US US17/086,666 patent/US20220033377A1/en not_active Abandoned
2023
- 2023-03-07 US US18/118,549 patent/US20240150317A1/en active Pending

Also Published As

Publication number	Publication date
JP5213715B2 (ja)	2013-06-19
US20160185754A1 (en)	2016-06-30
IL190172A0 (en)	2008-08-07
MY149834A (en)	2013-10-31
NZ593930A (en)	2013-02-22
US20180118716A1 (en)	2018-05-03
RU2448102C2 (ru)	2012-04-20
EP1943240B1 (en)	2009-11-11
HK1130478A1 (en)	2009-12-31
CA2624045A1 (en)	2007-04-05
US20240150317A1 (en)	2024-05-09
KR20080049114A (ko)	2008-06-03
TWI424991B (zh)	2014-02-01
SI2053048T1 (sl)	2010-12-31
PT1943240E (pt)	2010-01-11
GB0519879D0 (en)	2005-11-09
AR055671A1 (es)	2007-08-29
CN102503898A (zh)	2012-06-20
HK1122553A1 (en)	2009-05-22
CN102503933B (zh)	2014-06-25
AU2006296367B2 (en)	2011-08-11
ZA200802416B (en)	2009-01-28
PL2053048T3 (pl)	2011-03-31
CA2745829A1 (en)	2007-04-05
EP1943240A2 (en)	2008-07-16
US20120095229A1 (en)	2012-04-19
RS51263B (sr)	2010-12-31
ES2350513T3 (es)	2011-01-24
US20190263782A1 (en)	2019-08-29
IL190172A (en)	2014-05-28
SI1943240T1 (sl)	2010-02-26
CY1110887T1 (el)	2015-06-10
TW200745036A (en)	2007-12-16
WO2007036713A2 (en)	2007-04-05
EP2053048A1 (en)	2009-04-29
PL1943240T3 (pl)	2010-04-30
CN101277948A (zh)	2008-10-01
TWI328580B (en)	2010-08-11
JP5654546B2 (ja)	2015-01-14
KR101307641B1 (ko)	2013-09-12
JP2009510039A (ja)	2009-03-12
EP2053048B1 (en)	2010-09-15
DE602006017004D1 (de)	2010-10-28
US9815816B2 (en)	2017-11-14
ME01466B (me)	2014-04-20
US20140378684A1 (en)	2014-12-25
RS51515B (en)	2011-06-30
TW201018660A (en)	2010-05-16
HRP20100620T1 (hr)	2010-12-31
MY145540A (en)	2012-02-29
CA2624045C (en)	2012-05-22
NO20081267L (no)	2008-04-30
DE602006010428D1 (de)	2009-12-24
JP2013063998A (ja)	2013-04-11
ATE481399T1 (de)	2010-10-15
US20090203905A1 (en)	2009-08-13
HRP20100019T1 (hr)	2010-02-28
UY29824A1 (es)	2007-04-30
CN102503898B (zh)	2015-03-25
US8163926B2 (en)	2012-04-24
PT2053048E (pt)	2010-11-10
US8865899B2 (en)	2014-10-21
ATE448218T1 (de)	2009-11-15
IL227574A (en)	2015-08-31
ES2335435T3 (es)	2010-03-26
CA2745829C (en)	2013-07-02
NO342152B1 (no)	2018-04-03
ME01531B (me)	2014-04-20
CN102503933A (zh)	2012-06-20
CY1110275T1 (el)	2015-01-14
WO2007036713A3 (en)	2007-06-14
DK2053048T3 (da)	2010-11-29
CN101277948B (zh)	2013-03-13
BRPI0616715A2 (pt)	2011-06-28
RU2008116573A (ru)	2009-11-10
US10344015B2 (en)	2019-07-09
AU2006296367A1 (en)	2007-04-05
EP2053048B8 (en)	2011-09-21
NZ566566A (en)	2011-08-26
SG165416A1 (en)	2010-10-28
US20220033377A1 (en)	2022-02-03

Publication	Publication Date	Title
GB0514078D0 (en)	2005-08-17	Chemical process
IL208667A0 (en)	2010-12-30	Chemical process
BRPI0714512A2 (pt)	2015-06-16	Compostos químicos
DE602006009980D1 (de)	2009-12-10	Biosensor
DK1907574T3 (da)	2014-01-20	Oligonukleotider
DE602006012689D1 (de)	2010-04-15	Überprüfungsverfahren
DK1943240T3 (da)	2010-03-01	Kemisk fremgangsmåde
GB0522061D0 (en)	2005-12-07	Chemical process
DK1955066T3 (da)	2014-05-05	Membran-assay-fremgangsmåde
DE602006004709D1 (de)	2009-02-26	Beschichtungsverfahren
NO20055841D0 (no)	2005-12-08	Kjemiske forbindelser
ATE427413T1 (de)	2009-04-15	Kondensationsverfahren
GB0515926D0 (en)	2005-09-07	Chemical process
BRPI0610575A2 (pt)	2016-11-16	processo
GB0517051D0 (en)	2005-09-28	Chemical process
SE0500057D0 (sv)	2005-01-10	Chemical compounds
TH110856B (th)	2011-11-21	กรรมวิธีเชิงเคมี
DE602005022946D1 (de)	2010-09-23	Strukturierungsverfahren
NO20053978D0 (no)	2005-08-26	Process.
FI20041315A0 (fi)	2004-10-11	Prosessi
ATE447172T1 (de)	2009-11-15	Biosensor
GB0514137D0 (en)	2005-08-17	Chemical process
GB0508515D0 (en)	2005-06-01	Chemical process
GB0508808D0 (en)	2005-06-08	Chemical process
GB0512049D0 (en)	2005-07-20	Chemical process